Crystallization Tendency of Active Pharmaceutical Ingredients Following Rapid Solvent Evaporation-Classification and Comparison with Crystallization Tendency from Undercooled Melts

被引:147
作者
Van Eerdenbrugh, Bernard [1 ]
Baird, Jared A. [1 ]
Taylor, Lynne S. [1 ]
机构
[1] Purdue Univ, Sch Pharm & Pharmaceut Sci, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
基金
美国国家科学基金会;
关键词
crystallization; amorphous state; spin coating; solvent evaporation; classification; physical stability; DISSOLUTION BEHAVIOR; PHYSICAL STABILITY; DRUG; SOLUBILITY; KINETICS; STATE; POLYMORPHISM; DISPERSIONS; NUCLEATION; ADDITIVES;
D O I
10.1002/jps.22214
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, the crystallization behavior of a variety of compounds was studied following rapid solvent evaporation using spin coating. Initial screening to determine model compound suitability was performed using a structurally diverse set of 51 compounds in three different solvent systems [dichloromethane (DCM), a 1:1 (w/w) dichloromethane/ethanol mixture (MIX), and ethanol (EtOH)]. Of this starting set of 153 drug solvent combinations, 93 (40 compounds) were selected for further evaluation based on solubility, chemical solution stability, and processability criteria. These systems were spin coated and their crystallization was monitored using polarized light microscopy (7 days, dry conditions). The crystallization behavior of the samples could be classified as rapid (Class I: 39 cases), intermediate (Class II: 23 cases), or slow (Class III: 31 cases). The solvent system employed influenced the classification outcome for only four of the compounds. The various compounds showed very diverse crystallization behavior. Upon comparison of classification results with those of a previous study, where cooling from the melt was used as a preparation technique(1), a good similarity was found whereby 68% of the cases were identically classified. Multivariate analysis was performed using a set of relevant physicochemical compound characteristics. It was found that a number of these parameters tended to differ between the different classes. These could be further interpreted in terms of the nature of the crystallization process. Additional multivariate analysis on the separate classes of compounds indicated some potential in predicting the crystallization tendency of a given compound. (C) 2010 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:3826-3838, 2010
引用
收藏
页码:3826 / 3838
页数:13
相关论文
共 32 条
[1]   Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution [J].
Alonzo, David E. ;
Zhang, Geoff G. Z. ;
Zhou, Deliang ;
Gao, Yi ;
Taylor, Lynne S. .
PHARMACEUTICAL RESEARCH, 2010, 27 (04) :608-618
[2]   Stability study of amorphous valdecoxib [J].
Ambike, AA ;
Mahadik, KR ;
Paradkar, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 282 (1-2) :151-162
[3]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]   Mode of Action and Design Rules for Additives That Modulate Crystal Nucleation [J].
Anwar, Jamshed ;
Boateng, Papa Kofi ;
Tamaki, Reiko ;
Odedra, Sheetal .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (09) :1596-1600
[5]  
BAIRD JA, 2010, J PHARM SCI, DOI DOI 10.1002/JPS.22197
[6]   Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state [J].
Bhugra, Chandan ;
Pikal, Michael J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (04) :1329-1349
[7]  
BORNSIDE DE, 1987, J IMAGING TECHNOL, V13, P122
[8]   Cyclodextrins as pharmaccutical solubilizers [J].
Brewster, Marcus E. ;
Loftsson, Thorsteinn .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :645-666
[9]   Polymorphism in molecular crystals: Stabilization of a metastable form by conformational mimicry [J].
Davey, RJ ;
Blagden, N ;
Potts, GD ;
Docherty, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (07) :1767-1772
[10]   Correlating thermodynamic and kinetic parameters with amorphous stability [J].
Graeser, Kirsten A. ;
Patterson, James E. ;
Zeitler, J. Axel ;
Gordon, Keith C. ;
Rades, Thomas .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 37 (3-4) :492-498